$GNBT #OTCQB Generex Biotechnology Corp. (GNBT: OTCQB) | Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared Excellagen® Wound Conforming Gel Matrix with Three Dosage Options

http://www.otcmarkets.com/stock/GNBT/news?id=215268

Copyright 2018 – OTC Markets Group Inc.